Clinical Uptake of Antimicrobial Stewardship Recommendations Following Nanosphere Verigene Blood Culture Gram-Negative Reporting

References

• Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000;118 (1):146–155.
   PubMed Web of Science ®Google Scholar
• Kim SH, Kim KH, Kim HB, Kim NJ, Kim EC, Oh MD, Choe KW. Outcome of vancomycin treatment in patients with methicillin-sus-ceptible Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 2008;52 (1):192–197.
   PubMed Web of Science ®Google Scholar
• Perez KK, Olsen RJ, Musick WL, Cernoch PL, Davis JR, Land GA, Peterson LE, Musser JM. Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. Arch Pathol Lab Med 2013;137 (9):1247–1254.
   PubMed Web of Science ®Google Scholar
• Tojo M, Fujita T, Ainoda Y, Nagamatsu M, Hayakawa K, Mezaki K, Sakurai A, Masui Y, Yazaki H, Takahashi H, Miyoshi-Akiyama T, Totsuka K, Kirikae T, Ohmagari N. Evaluation of an automated rapid diagnostic assay for detection of Gram-negative bacteria and their drug-resistance genes in positive blood cultures. PLoS One 2014;9 (4):e94064.
   PubMed Web of Science ®Google Scholar
• Tziolos N, Giamarellos-Bourboulis EJ. Contemporary approaches to the rapid molecular diagnosis of sepsis. Expert Rev Mol Diagn 2016;16 (11):1201–1207.
   PubMed Web of Science ®Google Scholar
• Ledeboer NA, Lopansri BK, Dhiman N, Cavagnolo R, Carroll KC, Granato P, Thomson R Jr. , Butler-Wu SM, Berger H, Samuel L, Pancholi P, Swyers L, Hansen GT, Tran NK, Polage CR, Thomson KS, Hanson ND, Winegar R, Buchan BW. Identification of Gram-negative bacteria and genetic resistance determinants from positive blood culture broths by use of the Verigene Gram-negative blood culture multiplex microarray-based molecular assay. J Clin Microbiol 2015;53 (8):2460–2472.
   PubMed Web of Science ®Google Scholar
• Dekmezian M, Beal SG, Damashek MJ, Benavides R, Dhiman N. The SUCCESS model for laboratory performance and execution of rapid molecular diagnostics in patients with sepsis. Proc (Bayl Univ Med Cent) 2015;28 (2):144–150.
   PubMedGoogle Scholar
• Beal SG, Thomas C, Dhiman N, Nguyen D, Qin H, Hawkins JM, Dekmezian M, Benavides R. Antibiotic utilization improvement with the Nanosphere Verigene Gram-Positive Blood Culture assay. Proc (Bayl Univ Med Cent) 2015;28 (2):139–143.
   PubMedGoogle Scholar
• Bork JT, Leekha S, Heil EL, Zhao L, Badamas R, Johnson JK. Rapid testing using the Verigene Gram-negative blood culture nucleic acid test in combination with antimicrobial stewardship intervention against Gram-negative bacteremia. Antimicrob Agents Chemother 2015;59 (3):1588–1595.
   PubMed Web of Science ®Google Scholar
• Hill JT, Tran KD, Barton KL, Labreche MJ, Sharp SE. Evaluation of the nanosphere Verigene BC-GN assay for direct identification of Gram-negative bacilli and antibiotic resistance markers from positive blood cultures and potential impact for more-rapid antibiotic interventions. J Clin Microbiol 2014;52 (10):3805–3807.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Hitomi S, Yaguchi Y, Tamai K, Ueda A, Kamata K, Tokuda Y, Koganemaru H, Kurihara Y, Ishikawa H, Yanagisawa H, Yanagihara K. Prospective intervention study with a microarray-based, multiplexed, automated molecular diagnosis instrument (Verigene system) for the rapid diagnosis of bloodstream infections, and its impact on the clinical outcomes. J Infect Chemother 2015;21 (12):849–856.
   PubMedGoogle Scholar
• Walker T, Dumadag S, Lee CJ, Lee SH, Bender JM, Cupo Abbott J, She RC. Clinical impact of laboratory implementation of Verigene BC-GN microarray-based assay for detection of Gram-negative bacteria in positive blood cultures. J Clin Microbiol 2016;54 (7):1789–1796.
   Web of Science ®Google Scholar
• Ng TM, Khong WX, Harris PN, De PP, Chow A, Tambyah PA, Lye DC. Empiric piperacillin-tazobactam versus carbapenems in the treatment of bacteraemia due to extended-spectrum beta-lactamase—producing Enterobacteriaceae. PLoS One 2016;11 (4):e0153696.
   Web of Science ®Google Scholar
• Joo EJ, Park DA, Lee NR, Moon SY, Choi JK, Ko JH, Peck KR. Impact of appropriateness of empiric therapy on outcomes in community-onset bacteremia by extended-spectrum-beta-lactamase producing Escherichia coli and Klebsiella pneumoniae definitively treated with carbapenems. Eur J Clin Microbiol Infect Dis 2017 Jun 23 [Epub ahead of print].
   Google Scholar